CorDx Tyfast COVID-19 Ag Rapid Test Rx
Simple Point-Of-Care Device To Directly Detect Sars-Cov-2 Viral Targets From Clinical Specimens In Near-Patient Settings. 510(k) K253882, from CorDx, Inc. (Alpharetta, GA). Product code QVF, class 2.
As of Nov 19, 2026, K253882 is an FDA 510(k) held by CorDx, Inc., substantially equivalent on Jun 1, 2026 after 179 days, with no recalls tied to it in FDA's recall database.
- Review time: 179 days
- Recalls: 0
The CorDx Tyfast COVID-19 Ag Rapid Test Rx is a visually read lateral flow immunoassay intended for the rapid, qualitative detection of SARS-CoV-2 nucleocapsid protein antigen directly in anterior nasal swab specimens from individuals with signs and symptoms of upper respiratory tract infection.
- Nano-Check™ COVID-19 Antigen TestK231187 · Nano-Ditech Corporation · Jan 23, 2024
- Healgen Rapid COVID-19 Antigen TestK232377 · Healgen Scientific,, LLC · Apr 19, 2024
- Nano-Check™ COVID-19 Antigen TestK231187 · Nano-Ditech Corporation · Jan 23, 2024
- Sofia 2 SARS Antigen+ FIA; Sofia 2 SARS Antigen+ FIA Control Swab SetK233688 · Quidel Corporation · Dec 13, 2023
- Document
- 510(k) summary (PDF) ↗
- Type
- Dual Track
- Received
- Dec 4, 2025
- Review panel
- Microbiology
- Regulation
- 21 CFR 866.3982
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files